Original Research ARTICLE
Association of Aryl Hydrocarbon Receptor-Related Gene Variants with the Severity of Autism Spectrum Disorders
- 1Department of Neurobiology and Behavior, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
- 2Research Center for Child Mental Development, University of Fukui, Fukui, Japan
- 3Department of Occupational Therapy, Graduate School of Health Sciences, Nagasaki University, Nagasaki, Japan
- 4Nagasaki Municipal Welfare Center for the Handicapped, Nagasaki, Japan
- 5Sasebo Child Development Center, Sasebo, Japan
- 6Department of Neuropsychiatry, Teikyo University School of Medicine, Tokyo, Japan
- 7Department of Physical and Health Education, Graduate School of Education, The University of Tokyo, Tokyo, Japan
- 8Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan
Exposure to environmental chemicals, such as dioxin, is known to have adverse effects on the homeostasis of gonadal steroids, thereby potentially altering the sexual differentiation of the brain to express autistic traits. Dioxin-like chemicals act on the aryl hydrocarbon receptor (AhR), polymorphisms, and mutations of AhR-related gene may exert pathological influences on sexual differentiation of the brain, causing autistic traits. To ascertain the relationship between AhR-related gene polymorphisms and autism susceptibility, we identified genotypes of them in patients and controls and determined whether there are different gene and genotype distributions between both groups. In addition, to clarify the relationships between the polymorphisms and the severity of autism, we compared the two genotypes of AhR-related genes (rs2066853, rs2228099) with the severity of autistic symptoms. Although no statistically significant difference was found between autism spectrum disorder (ASD) patients and control individuals for the genotypic distribution of any of the polymorphisms studied herein, a significant difference in the total score of severity was observed in rs2228099 polymorphism, suggesting that the polymorphism modifies the severity of ASD symptoms but not ASD susceptibility. Moreover, we found that a significant difference in the social communication score of severity was observed. These results suggest that the rs2228099 polymorphism is possibly associated with the severity of social communication impairment among the diverse ASD symptoms.
Reports of the incidence of autism spectrum disorder (ASD) – characterized by two core symptoms: communication and social deficits and fixed or repetitive behavior (1) – have been increasing in recent years (2). The prevalence of ASD rose from 1 per 5,000 children in 1975 to 1 per 110 children in 2009 in the United States (3). Current estimates of the break up of possible reasons are as follows: about 25%, attributed to diagnostic accretion; 15%, to the growing awareness of ASD; 10%, to advanced parental age; and 4%, to geographic clustering. However, for the remaining 46% of the cases, the underlying reasons remain unclear (3). Although a strong genetic contribution to ASD has been suggested by many previous studies (4, 5), the syndrome has many features that are not well explained by genetic factors alone (6). Therefore, some researchers have considered projecting ASD as a multifactorial disorder with both genetic and environmental influences (7–9).
The “extreme male brain” (EMB) theory is one of the leading hypotheses for explaining the mechanism of ASD (10, 11). The EMB theory suggests that exposure to imbalanced levels of gonadal steroids (androgen and estrogen) could exert a pathological influence on the sexual differentiation of the brain during the fetal period, which may cause ASD traits in such individuals. Prenatal gonadal steroid levels in the amniotic fluid are correlated with ASD traits in children at 12 and 24 months of age (12, 13). Exposure to environmental chemicals, especially dioxin-like chemicals, is known to have adverse effects on the homeostasis of gonadal steroids, thereby altering the sexual differentiation of the brain to express ASD traits. Dioxin-like chemicals, such as tetrachlorodibenzo-p-dioxin (TCDD), polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs), and some polychlorinated biphenyls (PCBs), act on the aryl hydrocarbon receptor (AhR) (14, 15). Recent accumulating evidence suggests that ligand-activated AhR might alter both estrogen and androgen signals (16, 17). These findings further support that dioxin-like chemical exposure during the fetal period may exert pathological influences on sexual differentiation of the brain, causing ASD traits (18).
Epidemiological studies have shown that PCB exposure at low levels can exert adverse clinical and subclinical effects on sociocognitive functions (19–23). Depending on geographical location, children might be exposed varying background levels of toxic environmental chemicals. Whether the adverse effects are expressed or not depends on inherent individual vulnerability to the environmental chemicals. Therefore, with regard to dioxin-like chemicals in particular, the vulnerability could be modified by an individual’s receptor (AhR)-related gene polymorphisms.
Numerous studies have investigated the association between AhR-related gene polymorphisms and reproductive system diseases, such as endometriosis or infertility (24–27), because these diseases are regarded as complex traits in which genetic and environmental factors contribute to the disease phenotype (28). Various studies on AhR-related gene polymorphisms, as explored by a recent meta-analysis on endometriosis risk in Asian populations (27), have considered AhR Arg554Lys and AhR nuclear translocator (ARNT) Val189Val as potential candidates (24–27). Although it may be hypothesized that these two polymorphisms contribute to the ASD phenotype by modulating vulnerability to the environmental chemicals, little evidence is available on the relationship between ASD and AhR-related gene polymorphisms in humans, with the exception of the investigation on ARNT2 polymorphisms (29). Therefore, the current study aimed to determine whether polymorphisms of AhR-related genes (AhR Arg554Lys and ARNT Val189Val) contribute to ASD susceptibility and/or severity.
First, to ascertain the relationship between the two AhR-related gene polymorphisms and ASD susceptibility, we identified these genotypes in patients and controls and determined whether there are different gene and genotype distributions between the two groups. Second, to clarify the relationships between the polymorphisms and the severity of ASD, we compared the genotypes of AhR-related genes with the severity of ASD symptoms using the Childhood Autism Rating Scale (CARS) (30). Finally, we applied factor analysis to the CARS scale and tried to identify several core symptoms, such as social communication, stereotypies, and sensory abnormalities (31). We also tried to evaluate the relationship between the severity of these symptoms and the AhR-related gene polymorphisms because the disease severity is not always consistent across symptoms; rather, the relative severity of different symptoms varies among individual cases (32, 33).
Materials and Methods
Ninety-five children and adults with ASD participated in the present study. Participants with ASD were recruited in two different geographical regions, Tokyo and Nagasaki, in Japan. The participants in Tokyo consisted of 68 ASD patients (58 males and 10 females, mean age = 12.43 ± 7.7 years) and were recruited from the outpatient clinics of the Department of Psychiatry in the University of Tokyo Hospital. The participants in Nagasaki consisted of 27 ASD patients (26 male and 1 female patients, mean age = 11.35 ± 3.2 years), and they were recruited from two day-care facilities in Nagasaki prefecture for patients with developmental disorders. In both areas, the diagnoses were made by two or more senior pediatric-psychiatric clinicians through structured interviews and reviews of clinical records according to the DSM-IV criteria (34). Among the 68 patients in Tokyo, 66 were diagnosed with autistic disorder and 2 with Asperger’s disorder. Among the 27 patients in Nagasaki, 17 were diagnosed with autistic disorder and 10 with Asperger’s disorder. Both patient groups excluded individuals with pervasive developmental disorder, not otherwise specified (PDD-NOS). Participants with severe intellectual disability were excluded if they had a full-scale intelligence quotient (FSIQ) <50 on the Wechsler Intelligence Scale for Children (35), Wechsler Adult Intelligence Scale (36), or the Tanaka–Binet Intelligence Scale (a Japanese revised version of the Stanford–Binet Intelligence Scale) (37).
Additionally, 527 adults (332 men and 195 women patients, mean age = 40.9 ± 9.7 years) were recruited as control participants from the nearby community around the University of Tokyo Hospital, without any psychiatric disorder disturbing their work function. The Mini-International Neuropsychiatric Interview (MINI) (38) and other surveys were administered in the recruitment of controls to exclude those who had current or lifetime history of mental disorders. These individuals were recruited from the community through advertisements as well as an online solicitation.
The race/ethnicity of all participants was Japanese. Potential participants were also excluded if they had any history of substance abuse, recent substance use, head trauma with loss of consciousness, significant fetal exposure to alcohol or drugs, perinatal or neonatal complications, and neurological disorders or medical conditions.
The present study was approved by the Ethical Committees of the University of Tokyo Graduate School of Medicine and the Nagasaki University Graduate School of Biomedical Sciences. All participants or parents of the affected individuals provided written informed consent prior to their participation in this study. The experimental protocol was conducted in accordance with the Declaration of Helsinki.
Assessment of the Severity of ASD
The severity of ASD was assessed on the basis of the Japanese version of the CARS (30). The assessment by CARS was performed at the same time as genomic sampling in this study. The CARS is a behavior-based clinical scale developed by observation and interaction with ASD patients. The scale has been reported to have a high degree of internal consistency, inter-rater and test–retest reliability, high criterion-related validity, and good discriminant validity (39). The severity was rated for 15 items (“Relationship to People,” “Imitation,” “Emotional Response,” “Body Use,” “Object Use,” “Adaptation to Change,” “Visual Response,” “Listening Response,” “Taste, Smell, Touch Response and Use,” “Fear and Nervousness,” “Verbal Communication,” “Non-verbal Communication,” “Activity Level,” “Level and Consistency of Intellectual Response,” and “General Impressions”) on a scale of 1 (normal for child’s age) to 4 (severely abnormal) in units of 0.5. In this study, experienced clinical psychologists rated the subjects based on behavioral observation and parental reports.
Genomic DNA was extracted from the peripheral blood using the standard phenol–chloroform method for set A and from the oral mucosa of the participants using the QIAamp DNA Micro Kit (Qiagen, Tokyo, Japan) in set B. All participants were genotyped by real-time polymerase chain reaction (PCR) analysis using Roche LightCycler 480 II (Roche Diagnostics, Tokyo, Japan) for the following two single nucleotide polymorphisms (SNPs): AhR codon 554 in exon 10 (G/A, Arg to Lys, rs2066853) and ARNT codon 189 in exon 7 (G/C, silent mutation, rs2066853) (24–28). Reactions were performed in 5-μl reactions, each containing 5 ng genomic DNA, 2.75 μl HPLC water, 0.25 μl of each TaqMan probe (Applied Biosystems, Foster City, CA, USA), and 2.5 μl TaqMan PCR Master Mix (Applied Biosystems, Foster City, CA, USA). The PCR cycling conditions consisted of a 10-min cycle at 95°C, followed by 60 cycles of 95°C for 30 s and 60°C for 30 s. Five microliters of HPLC water and Mater Mix were used as a negative PCR control in each amplification. Allele calling was performed using LightCycler CW 1.5 software (Roche Diagnostics).
Analyses proceeded in four steps. First, the chi-squared test was used to investigate the relationship between each AhR-related gene polymorphism and susceptibility to ASD. Next, analysis of variance (ANOVA) was used to compare the severity of ASD among AhR-related gene polymorphisms. Third, to assess the severity corresponding to several core behavioral symptoms of ASD, factor analysis with Varimax rotation for CARS was performed, and the factor score was calculated by regression method for each subject. Finally, ANOVA was also used to assess the effects of AhR-related gene polymorphisms for each severity of discriminative behavioral symptoms of ASD identified by the prior factor analysis. The chi-squared test, factor analysis, and multinomial logistic regression analysis were performed using IBM SPSS 20.0 for Windows (Statistical Package for the Social Sciences; IBM). The ANOVA was performed using Anovakun software (version 188.8.131.52) in the R software space (version 3.2.0. for Windows, R2).
Genotypes of AhR-Related Genes and Susceptibility to and Severity of ASD
The genotype and allele frequencies of AhR codon 554 and ARNT codon 189 are shown in Table 1. Fourteen samples with ARNT codon 189 in healthy participants were excluded from the data because the signal failed to be detected as a result of misamplification. The genotype distributions were in Hardy–Weinberg equilibrium (p > 0.05). Comparisons between genotype groups did not demonstrate statistically significant differences with regard to children’s age, sex, or IQ level. To investigate the relationship between each AhR-related gene polymorphism and susceptibility to ASD, the chi-squared test was used to evaluate the genotype distribution according to developmental status. No statistically significant association was observed between any of the polymorphisms and susceptibility to ASD.
Next, to investigate the relationship between each AhR-related gene polymorphism and the severity of ASD, one-way ANOVA was used for the total CARS score of ASD patients as the dependent variable and the genotype of each AhR-related gene polymorphism as the independent variable. There was a statistically significant difference between genotype groups for ARNT polymorphism (rs2228099), as determined by ANOVA [F(2,92) = 5.69, p < 0.01, effect size f = 0.352, power = 0.865]. Holm’s sequentially rejective Bonferroni post hoc test revealed that the total CARS score of the GG genotype was statistically significantly higher than those of the GC genotypes [t(92) = 3.17, p < 0.05], whereas there were no statistically significant differences in score between the CC genotype and both genotype groups [GC-CC: t(92) = 2.18; GG-CC: t(92) = 0.10]. Additionally, there were no statistically significant differences between genotype groups for AhR polymorphism (rs2066853) [F(2,92) = 0.26]. Taken together, these results suggest that ARNT polymorphism modified the severity of ASD among the AhR-related genes examined in the current study.
Factor Analysis of CARS
To assess the severity according to several core behavioral symptoms of ASD, factor analysis with Varimax rotation was performed for the CARS data. The analysis produced three factors with eigenvalues greater than one. These factors accounted for 55.1% of the common variance. Table 2 shows the factor loadings and the descriptive statistics for each item of the CARS data. The first factor was “social communication,” which consisted of “verbal communication,” “non-verbal communication,” “imitation,” “visual response,” “relating to people,” and “level and consistency,” and assessed the proficiency of social communication and reciprocity. The second factor was “sensory and emotional response,” which consisted of “activity level,” “object use,” “emotional response,” “taste, smell, touch, and response,” “listening response,” and “fear or nervousness,” and assessed abnormalities of sensory and emotional responses. The third factor was “stereotypies,” which consisted of “total impression,” “adaptation to change,” and “body use” and assessed restricted, repetitive patterns of behavior. These three factors well recapitulated the core behavioral symptoms of ASD, as described by the DSM-5, and the results were consistent to those of a similar previous study applying a factor analysis to CARS data (31). Therefore, we used the factor score for each of the three factors in the association analysis between the genotype of AhR-related genes and the severity of each of the three behavioral symptoms of ASD.
Table 2. Factor loadings from factor analysis with Varimax rotationa, mean, and SD of the 15 items of the CARS.
Genotypes of AhR-Related Genes and the Severity of the Core Behavioral Symptoms of ASD
To investigate relationship between each AhR-related gene polymorphism and the severity of several of the core symptoms of ASD, one-way ANOVA was performed for the factor score of CARS of ASD patients as the dependent variable, with the genotype of each AhR-related gene polymorphism as the independent variable. Similar to the result for the total score, there were no statistically significant associations between factor scores and genotype groups for AhR polymorphism (rs2066853) (Table 3). However, for ARNT polymorphism (rs2228099), a significant difference was observed for the factor score of the “social communication” factor, but not for the “sensory and emotional response” factor or “stereotypies” factor. Holm’s sequentially rejective Bonferroni post hoc test revealed that the factor score of the GG genotype was statistically significantly higher than that of the GC genotypes [t(92) = 3.25, p < 0.01], whereas there were no statistically significant differences in score between CC genotype and both genotype groups [GC-CC: t(92) = 1.24; GG-CC: t(92) = 1.09] (Figure 1).
Figure 1. Three factor scores of CARS (mean ± SE) for each polymorphism of AhR-related genes. The statistical threshold was corrected with Holm’s sequentially rejective Bonferroni adjustment for multiple comparisons. (A) AhR (rs2066853) and (B) ARNT (rs2228099). Note: **p < 0.01.
In this study, no statistically significant difference was found between ASD patients and control individuals for the genotypic distribution of any of the polymorphisms studied herein. However, a significant difference in the severity score, especially for the symptom of “social communication,” was observed in ARNT codon 189 polymorphism, suggesting that the ARNT polymorphism modifies the severity of ASD symptoms but not susceptibility to ASD.
A large twin population study estimated that environmental factors common to twins explain about 55% of the liability to ASD, while genetic factors explain 35% (9). As one of the environmental factors for the liability to ASD, the possible involvement of dioxin and/or dioxin-like environmental chemicals was investigated. Although many environmental chemicals affect neurodevelopment in humans, we focused on dioxin and dioxin-like chemicals because we have shown that higher levels of dioxin-like PCBs in the cord blood appear as a manifestation of ASD-like behaviors in 4-month-old infants (40), and also because maternal exposure to such environmental chemicals possibly disrupts fetal gonadal hormone balances, which could lead to EMB (12, 13). The current study investigated the effects of AhR-related gene polymorphisms on ASD susceptibility and/or severity to determine the relationship between possible vulnerability to dioxin and dioxin-like PCBs and ASD susceptibility and/or severity because dioxin and dioxin-like PCBs at low levels have spread almost uniformly throughout the country. AhR-related gene polymorphisms have been found to underlie physical diseases such as breast cancer and endometriosis, but no report is available on the effect of these polymorphisms on mental disorders. To the best of our knowledge, the present study is the first report to clarify the association between ARNT, an AhR-related gene polymorphism, and the severity of ASD symptoms.
The current study could not clarify the mechanism underlying how the ARNT polymorphism modifies ASD severity in terms of social communication since no functional analysis of the ARNT polymorphism was carried out. However, a possible explanation is that this polymorphism might alter the gonadal hormone balance in the prenatal period through alterations in the AhR signaling pathway and could thus affect ASD severity. It is well known that the sexual differentiation of the human brain depends on prenatal exposure levels of androgens (41), and according to the EMB hypothesis, gonadal hormone imbalances make the autistic brain develop beyond that of the typical male (10, 11). In fact, evidence in favor of the positive association between autistic symptomatology and the levels of fetal testosterone has been found (13, 42). Although there is no evidence for a direct interaction between fetal testosterone and the AhR signaling pathway, the AhR–ARNT heterodimer has been reported to have estrogenic functions in the absence of estrogen (16). Therefore, some sort of functional variant induced by ARNT polymorphisms might alter the prenatal exposure levels of gonadal hormone and have adverse effects on sexual differentiation of the brain.
Our preliminary results showed a significant association between the severity of ASD and polymorphism at ARNT codon 189, which results in a silent mutation (Val189Val). Although the exact molecular and physiological mechanisms underlying this effect remain unknown, a recent study suggested that silent mutations may contribute to mental disorders (43). Therefore, to clarify the possible meaning of this association, further genetic analyses are necessary. Such analyses should particularly address the interaction with other genetic polymorphisms, both upstream and downstream from rs2228099, which may interfere with splicing and/or ARNT mRNA stability.
One of the most interesting findings in the current study is that the ARNT polymorphism is specifically associated with the severity of social communication impairment among the diverse ASD symptoms. The diversity of ASD symptoms is an obstacle for elucidating the pathology and etiology, and the core behavioral symptoms defining ASD are genetically heterogeneous in that there are no overlapping genes acting on any of these traits. New, efficient models have been proposed to describe the diverse symptoms by evaluating the severity of the major components of impairments (44, 45). According to this strategy, we surmised that the ARNT polymorphism correlated with the severity of social communication difficulties but not with rigid and repetitive behaviors.
Several limitations of the present study should be noted and taken into consideration in future studies. First, the main limitation is the relatively small patient group. We did not observe a significant association between genetic SNPs and susceptibility to ASD in this study, and one possible explanation is the small sample number, as a large number of subjects are needed for case–control studies based on the frequency distribution. Therefore, studies involving a larger number of subjects are essential to generalize our results. Second, the number and age of subjects between the cases and control groups were not well matched. It is possible that the risk modulation by AhR-related gene polymorphism depends on the fetal environment and exposure of the mother, which would be expected to vary across different time periods. The disease risk imparted by the allele would therefore be expected to vary in different age groups. Third, although we have used the MINI to ensure the quality of the controls, it is important to note that the MINI does not necessarily exclude ASD. In addition, although the controls also need to be technically screened for family history of ASD or developmental disorders, MINI does not exclude individuals with unidentified Asperger’s or broader autism phenotypes, which is a key concern in the recruitment of controls in this study. In this regard, tools such as the Social Responsiveness Scale (SRS) may have provided a better index (46). This heterogeneity of our sample may be another possible explanation for our negative findings between groups described above. Finally, we used only one clinical scale (CARS) to assess the severity of ASD because we did not obtain full data for any other clinical scale. The ratings by CARS are not invariant across the life span (e.g., non-verbal ability in a 4-year-old individual may not be as severe as that in a 20-year-old individual), although the majority of our clinical samples consisted of children aged 18 years and younger, and the genotype groups were confirmed to not be different with regard to age. However, the heterogeneity in age within our ASD samples could introduce a bias for severity assessment with respect to genetics, and it would also the affect factor analysis process. An informative measure such as SRS adjusted for age may have thus been more useful as a severity measure for purposes of this study (46). Therefore, future studies are needed to assess various aspects of behavioral symptoms of broad social communication using other established scales and to clarify the contribution of ARNT gene polymorphism to aspects of social communication.
In conclusion, the current results showed that individuals with the ARNT GG genotype had more severely impaired social communication than those with GC genotype in ASD, indicating that the differences in social functioning in ASD patients may be modulated by ARNT variants. Considering that ARNT is a component of AhR cascades, vulnerability to environment chemicals, especially dioxin-like chemicals may affect the severity of impaired social communication, although the functional analysis of ARNT gene polymorphism remains to be performed. To identify the neuronal mechanism underlying this effect, combining the present experimental paradigm with neurophysiological indicators of brain activities is warranted in future studies.
TF and SN were involved in conducting the experiment, analyzing and interpreting data, and drafting the article. RI, JM, and CK were involved in recruiting the participants and diagnosing the participants with ASD. MT, TS, and NK were involved in conducting the experiment, analyzing and interpreting data, and revising the article. KS conceived of the study, participated in its design and coordination, and drafted the manuscript. All the authors have read and approved the final manuscript.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
This work was supported by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (KAKENHI: grant numbers 25461774 to KS, grant number 15K01753 to TF).
AhR, aryl hydrocarbon receptor; ARNT, aryl hydrocarbon receptor nuclear translocator; ASD, autism spectrum disorder; CARS, Childhood Autism Rating Scale; DSM, diagnostic and statistical manual of mental disorders; EMB, extreme male brain; IQ, intelligence quotient; PBDE, polybrominated diphenyl ether; PCDD/Fs, polychlorinated dibenzo-p-dioxins and dibenzofurans; PCB, polychlorinated biphenyl; SNP, single nucleotide polymorphisms; TCDD, tetrachlorodibenzo-p-dioxin.
2. Boyle CA, Boulet S, Schieve LA, Cohen RA, Blumberg SJ, Yeargin-Allsopp M, et al. Trends in the prevalence of developmental disabilities in US children, 1997-2008. Pediatrics (2011) 127(6):1034–42. doi:10.1542/peds.2010-2989
9. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry (2011) 68(11):1095–102. doi:10.1001/archgenpsychiatry.2011.76
13. Auyeung B, Baron-Cohen S, Ashwin E, Knickmeyer R, Taylor K, Hackett G, et al. Fetal testosterone predicts sexually differentiated childhood behavior in girls and in boys. Psychol Sci (2009) 20(2):144–8. doi:10.1111/j.1467-9280.2009.02279.x
14. Helmig S, Seelinger JU, Döhrel J, Schneider J. RNA expressions of AHR, ARNT and CYP1B1 are influenced by AHR Arg554Lys polymorphism. Mol Genet Metab (2011) 104(1–2):180–4. doi:10.1016/j.ymgme.2011.06.009
15. Wahl M, Guenther R, Yang L, Bergman A, Straehle U, Strack S, et al. Polybrominated diphenyl ethers and arylhydrocarbon receptor agonists: different toxicity and target gene expression. Toxicol Lett (2010) 198(2):119–26. doi:10.1016/j.toxlet.2010.06.001
16. Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature (2003) 423(6939):545–50. doi:10.1038/nature01606
17. Del Pino Sans J, Clements KJ, Suvorov A, Krishnan S, Adams HL, Petersen SL. Developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin may alter LH release patterns by abolishing sex differences in GABA/glutamate cell number and modifying the transcriptome of the male anteroventral periventricular nucleus. Neuroscience (2016) 329:239–53. doi:10.1016/j.neuroscience.2016.04.051
21. Nishijo M, Tai PT, Nakagawa H, Maruzeni S, Anh NT, Luong HV, et al. Impact of perinatal dioxin exposure on infant growth: a cross-sectional and longitudinal studies in dioxin-contaminated areas in Vietnam. PLoS One (2012) 7(7):e40273. doi:10.1371/journal.pone.0040273
22. Nowack N, Wittsiepe J, Kasper-Sonnenberg M, Wilhelm M, Schölmerich A. Influence of low-level prenatal exposure to PCDD/Fs and PCBs on empathizing, systemizing and autistic traits: results from the Duisburg birth cohort study. PLoS One (2015) 10(6):e0129906. doi:10.1371/journal.pone.0129906
23. Tran NN, Pham TT, Ozawa K, Nishijo M, Nguyen AT, Tran TQ, et al. Impacts of perinatal dioxin exposure on motor coordination and higher cognitive development in Vietnamese preschool children: a five-year follow-up. PLoS One (2016) 11(1):e0147655. doi:10.1371/journal.pone.0147655
24. Tsuchiya M, Katoh T, Motoyama H, Sasaki H, Tsugane S, Ikenoue T. Analysis of the AhR, ARNT, and AhRR gene polymorphisms: genetic contribution to endometriosis susceptibility and severity. Fertil Steril (2005) 84(2):454–8. doi:10.1016/j.fertnstert.2005.01.130
25. Wu CH, Guo CY, Yang JG, Tsai HD, Chang YJ, Tsai PC, et al. Polymorphisms of dioxin receptor complex components and detoxification-related genes jointly confer susceptibility to advanced-stage endometriosis in the taiwanese han population. Am J Reprod Immunol (2012) 67(2):160–8. doi:10.1111/j.1600-0897.2011.01077.x
26. Merisalu A, Punab M, Altmäe S, Haller K, Tiido T, Peters M, et al. The contribution of genetic variations of aryl hydrocarbon receptor pathway genes to male factor infertility. Fertil Steril (2007) 88(4):854–9. doi:10.1016/j.fertnstert.2006.12.041
27. Zheng NN, Bi YP, Zheng Y, Zheng RH. Meta-analysis of the association of AhR Arg554Lys, AhRR Pro185Ala, and ARNT Val189Val polymorphisms and endometriosis risk in Asians. J Assist Reprod Genet (2015) 32(7):1135–44. doi:10.1007/s10815-015-0505-3
30. Schopler E, Reichler RJ, DeVellis RF, Daly K. Toward objective classification of childhood autism: childhood autism rating scale (CARS). J Autism Dev Disord (1980) 10(1):91–103. doi:10.1007/BF02408436
32. Ronald A, Happé F, Bolton P, Butcher LM, Price TS, Wheelwright S, et al. Phenotypic and genetic overlap between autistic traits at the extremes of the general population. J Am Acad Child Adolesc Psychiatry (2006) 45(10):1206–14. doi:10.1097/01.chi.0000230165.54117.41
38. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 59:22–33.
39. Parks LK, Hill DE, Thoma RJ, Euler MJ, Lewine JD, Yeo RA. Neural correlates of communication skill and symptom severity in autism: a voxel-based morphometry study. Res Autism Spectr Disord (2009) 3(2):444–54. doi:10.1016/j.rasd.2008.09.004
40. Doi H, Nishitani S, Fujisawa TX, Nagai T, Kakeyama M, Maeda T, et al. Prenatal exposure to a polychlorinated biphenyl (PCB) congener influences fixation duration on biological motion at 4-months-old: a preliminary study. PLoS One (2013) 8(3):e59196. doi:10.1371/journal.pone.0059196
43. Takata A, Ionita-Laza I, Gogos JA, Xu B, Karayiorgou M. De novo synonymous mutations in regulatory elements contribute to the genetic etiology of autism and schizophrenia. Neuron (2016) 89(5):940–7. doi:10.1016/j.neuron.2016.02.024
44. Gebregziabher M, Shotwell MS, Charles JM, Nicholas JS. Comparison of methods for identifying phenotype subgroups using categorical features data with application to autism spectrum disorder. Comput Stat Data Anal (2012) 56(1):114–25. doi:10.1016/j.csda.2011.06.014
45. Bitsika V, Sharpley CF, Orapeleng S. An exploratory analysis of the use of cognitive, adaptive and behavioural indices for cluster analysis of ASD subgroups. J Intellect Disabil Res (2008) 52(11):973–85. doi:10.1111/j.1365-2788.2008.01123.x
Keywords: autism spectrum disorder, aryl hydrocarbon receptor, aryl hydrocarbon receptor nuclear translocator, polymorphism, social communication, severity
Citation: Fujisawa TX, Nishitani S, Iwanaga R, Matsuzaki J, Kawasaki C, Tochigi M, Sasaki T, Kato N and Shinohara K (2016) Association of Aryl Hydrocarbon Receptor-Related Gene Variants with the Severity of Autism Spectrum Disorders. Front. Psychiatry 7:184. doi: 10.3389/fpsyt.2016.00184
Received: 05 July 2016; Accepted: 31 October 2016;
Published: 16 November 2016
Edited by:Ashok Mysore, St. John’s Medical College Hospital, India
Reviewed by:Kürşat Altınbaş, Çanakkale Onsekiz Mart University, Turkey
Meera Purushottam, National Institute of Mental Health and Neurosciences, India
Copyright: © 2016 Fujisawa, Nishitani, Iwanaga, Matsuzaki, Kawasaki, Tochigi, Sasaki, Kato and Shinohara. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kazuyuki Shinohara, firstname.lastname@example.org